Before starting semaglutide, inform your ADHD medication provider that you are beginning a GLP-1 treatment
Unlike Novo and Lillys products, Soliqua is not effective in managing weight loss, but experts say its broad distribution network in the GLP-1 market might give it an edge over other companies if Sanofi decides to jump back onto the GLP-1 obesity drug train
Family medicine physicians wrote 31% of tirzepatide prescriptions among patients with OSA, followed by nurse practitioners ( 24% ), internal medicine physicians ( 20% ), and physician assistants ( 9% )
Tips for staying motivated during the eighth week of Zepbound and beyond: Celebrate your wins
Some peptide formulations use IM delivery when the therapeutic intent involves prompt receptor activation or when a compounds molecular weight supports efficient diffusion from muscle tissue
Metabolic disease research, with the focus squarely on obesity, weight loss, and type 2 diabetes for now but with definite implications for PCOS and beyond, too